26 Jan 2015
NICE has issued further draft guidance which recommends empagliflozin, marketed by Boehringer Ingelheim, for treating type-2 diabetes.
Call for nominations for Awards Committee Chair
30 Oct 2024
James M Tanner Award - 2025 nominations open
30 Oct 2024
Would you like to host the BSPED annual meeting?
21 Oct 2024